Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.3954
+0.0354 (9.83%)
At close: May 12, 2025, 4:00 PM
0.3963
+0.0009 (0.23%)
After-hours: May 12, 2025, 6:56 PM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $8.84 million as of May 12, 2025. Its market cap has decreased by -72.36% in one year.
Market Cap
8.84M
Enterprise Value
4.34M
1-Year Change
-72.36%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $8.84M, a decrease of -84.56%. That is a compound annual growth rate of -38.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 8.05M | -41.47% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.41B |
| Johnson & Johnson | 372.70B |
| UnitedHealth Group | 342.80B |
| AbbVie | 339.36B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 230.84B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |